Abstract:Purpose: Sensitive to apoptosis gene (SAG; also known as RBX2 or ROC2) was originally cloned as a redox-inducible antioxidant protein and was later characterized as a RING component of SCF E3 ubiquitin ligases. SAG overexpression inhibits apoptosis induced by many stimuli both in vitro and in vivo. SAG mRNA was overexpressed in human lung tumor tissues with a correlation to poor patient survival. To investigate whether SAG serves as an anticancer target, we determined the effect of SAG silencing on cell proliferation, survival, and radiosensitivity. Experimental Design: SAG protein expression in human tumors was evaluated by immunohistochemical staining using tumor tissue arrays. SAG expression in cancer cells was knocked down by siRNA silencing. The anticancer effects of SAG silencing were evaluated by in vitro assays for cell growth and survival and by an in vivo orthotopic xenograft tumor model. Radiosensitization by SAG silencing of human cancer cells was determined by clonogenic survival assay. Apoptosis induction was evaluated by fluorescence-activated cell sorting analysis, caspase-3 activation assay, and Western blotting of apoptosis-associated proteins. Results: SAG was overexpressed in multiple human tumor tissues compared with their normal counterparts. SAG silencing selectively inhibited cancer cell proliferation, suppressed in vivo tumor growth, and sensitized radiation-resistant cancer cells to radiation. Mechanistically, SAG silencing induced apoptosis with accumulation of NOXA, whereas SAG overexpression reduced NOXA levels and shortened NOXA protein half-life. Conclusions: The findings showed that SAG E3 ubiquitin ligase plays an essential role in cancer cell proliferation and tumor growth and may serve as a promising anticancer and radiosensitizing target. Clin Cancer Res; 16(3); 814–24

Identification and Characterization of Genes Responsive to Apoptosis: Application of DNA Chip Technology and Mrna Differential Display.

Identification And Characterization Of Survival-Related Gene, A Novel Cell Survival Gene Controlling Apoptosis And Tumorigenesis

Global Genechip Profiling to Identify Genes Responsive to P53-Induced Growth Arrest and Apoptosis in Human Lung Carcinoma Cells

Identification Of Genes Associated With Apoptosis-Sensitive Acute Lymphoblastic Leukemia Responsive To Ionising Radiation By Bioinformatics Analyses

Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase

Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase As an Anticancer and Radiosensitizing Target.

Modulation of apoptosis signaling pathways and cell cycle regulation.

Identifying p53-independent apoptosis

Identification of cellular senescence-specific genes by comparative transcriptomics

Current Advances in the Application of Proteomics in Apoptosis Research

P53 and Its Downstream Proteins As Molecular Targets of Cancer

Identification of Novel Caspase/Autophagy-Related Gene Switch to Cell Fate Decisions in Breast Cancers

Studies On The Apoptosis-Related Genes Of Tf-1 Cell Line By Cdna-Rda Technique.

Network Analysis Identifies Drug Targets and Small Molecules to Modulate Apoptosis Resistant Cancers

Systematic Analysis of Time-Series Gene Expression Data on Tumor Cell-Selective Apoptotic Responses to HDAC Inhibitors.

Genetic mapping of anti-apoptosis pathways in myeloid progenitor cells.

Identifying Novel Candidate Genes Related to Apoptosis from a Protein-Protein Interaction Network

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death

Characterization of Prognostic Apoptosis-Related Gene Signature to Evaluate Glioma Immune Microenvironment and Experimental Verification

Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules.

Gene regulation associated with apoptosis.